A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

Please provide your email address to receive an email when new articles are posted on . Miller-Owen: Close to 8 million U.S. residents with diabetes are on insulin therapy, and the clear majority use ...

Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S. Food and Drug Administration, the lack of a label ...

The primary factor behind diabetes is that your body may not make enough insulin (type 1 diabetes) or it fails to respond to the insulin your pancreas releases, which is known as insulin resistance ...

One batch of Semglee prefilled insulin injection pens has been recalled by Mylan Pharmaceuticals for missing labels. Batch No. BF20003118, expiration August 2022 of Semglee (insulin glargine injection ...